CF Bankshares Inc.: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on May 13, 2020 and accepted by EDGAR at May 13, 2020, 10:18 ET.
Management's discussion and analysis
As filed, 1,843 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
(a) None.
(b) Not applicable.
PART II. Item 4
OTHER INFORMATION
(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended, during the three months ended March 31, 2020.
| Period | Total number of common shares purchased | Average price paid per common share | Total number of common shares purchased as part of publicly announced plans or programs | Maximum number of common shares that may yet be purchased under the plans or programs (3) | ||
|---|---|---|---|---|---|---|
| January 1 through January 31, 2020 | - | - | - | - | ||
| February 1 through February 29, 2020 | 1,869 | (1) | $14.31 | (2) | - | - |
| March 1 through March 31, 2020 | 4,753 | 10.45 | 4,753 | 61,000 | ||
| Total | 6,622 | $11.54 | 4,753 |
(1) Represents shares of common stock surrendered by officers and employees of the Company for payment of taxes upon vesting of restricted stock granted under the 2009 Equity Compensation Plan.
(2) Represents the average closing price of the Company’s common stock on February 27, 2020, which was the vesting date of the restricted stock surrendered for payment of taxes
(3) On March 12, 2020, the Board of Directors of Central Federal Corporation (the “Company) authorized a stock repurchase program pursuant to which the Company may repurchase up to 3% of the Company’s outstanding common stock over the period commencing March 13, 2020 and ending September 30, 2020. Under the stock repurchase program, the Company may purchase shares of its common stock from time to time through various means, including open market transactions and privately negotiated transactions.
Risk factors
As filed, 3,567 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following information updates and supplements our risk factors and should be read in conjunction with the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019:
The ongoing COVID-19 pandemic and measures intended to prevent its spread has had an adverse effect on our business, results of operations and financial condition, and such effects will depend on future developments, which are highly uncertain and are difficult to predict.
The COVID-19 pandemic is creating extensive disruptions to the global economy and to the lives of individuals throughout the world. Governments, businesses, and the public are taking unprecedented actions to contain the spread of COVID-19 and to mitigate its effects, including quarantines, travel bans, shelter-in-place orders, closures of businesses and schools, fiscal stimulus, and legislation designed to deliver monetary aid and other relief. While the scope, duration, and full effects of COVID-19 are rapidly evolving and not fully known, the pandemic and related efforts to contain it have disrupted global economic activity, adversely affected the functioning of financial markets, impacted interest rates, increased economic and market uncertainty, disrupted trade and supply chains, increased unemployment levels and decreased consumer confidence. These effects could materially affect our business, including by increasing the likelihood of loan delinquencies and defaults by our customers, which in turn would result in higher levels of non-performing loans and charge-offs that could negatively impact our financial condition and results of operations. In addition, if these effects continue for a prolonged period or result in sustained economic stress or recession, many of the risk factors identified in our Annual Report on Form 10-K could be exacerbated and such effects could have a material adverse impact on us in a number of ways related to credit, collateral, customer demand, funding, operations, and interest rate risk.
Governmental authorities have taken significant measures to provide economic assistance to individual households and businesses, stabilize the markets, and support economic growth. The success of these measures is unknown, and they may not be sufficient to fully mitigate the negative impact of the pandemic. Additionally, some measures, such as a suspension of consumer and commercial loan payments and the reduction in interest rates to near zero, may have a negative impact on our business, financial condition, liquidity, and results of operations. We could also face an increased risk of litigation and governmental and regulatory scrutiny as a result of the effects of the pandemic on market and economic conditions and actions governmental authorities take in response to those conditions.
The extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on future developments, which are highly uncertain and are difficult to predict, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 outbreak has subsided, we may continue to experience adverse impacts to our business as a result of the virus’s global economic impact, including the availability of credit, adverse impacts on our liquidity and any recession that has occurred or may occur in the future
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Interest expense | 3 months2020-01-01 to 2020-03-31 | $3.8m | us-gaap:InterestExpense |
| Income tax | 3 months2020-01-01 to 2020-03-31 | $517.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-01-01 to 2020-03-31 | $2.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-01-01 to 2020-03-31 | $0.31 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-01-01 to 2020-03-31 | 5,400,318 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2020-01-01 to 2020-03-31 | $34.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2020-01-01 to 2020-03-31 | $135.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-03-31 | $75.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2020-03-31 | $945.4m | us-gaap:Assets |
| Total liabilities | At period end2020-03-31 | $862.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-03-31 | $82.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001070680-20-000017. Last ingested by Listed: Nov 13, 2026, 01:50 ET. Listed shows no prices and gives no investment advice.